证券代码：688478 证券简称：晶升股份 公告编号：2024-033 南京晶升装备股份有限公司 关于参加 2023 年度半导体设备专场集体业绩说明会 暨 2024 年第一季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2024 年 5 月 15 日(星期三) 下午 15:00- 17:00 会议召开地点：上海证券交易所上证路演中心（网址： https://roadshow.sseinfo.com/） 会议召开方式：网络文字互动 投资者可于 2024 年 5 月 14 日(星期二)16:00 前通过公司邮 箱（cgee@cgee.com.cn）进行提问。公司将在文字互动环节对投资 者普遍关注的问题进行回答。 南京晶升装备股份有限公司（以下简称"公司"）已于 2024 年 4 月 30 日在上海证券交易所网站（www.sse.com.cn）披露了公司 2023 年年度报告以及 2024 年第一季度报告，为便于广大投资者更 全面深入地了解公司 2023 年度及 2024 年第一季 ...

Dividend and Profit Distribution - The company plans to distribute a cash dividend of RMB 2.00 per 10 shares, totaling RMB 27,610,993.00 (including tax) based on a total share capital of 138,054,965 shares after deducting repurchased shares[5]. - The board of directors has approved the profit distribution plan, which is subject to shareholder approval[6]. Financial Performance - The company has not achieved profitability since its listing, indicating ongoing investment and growth strategies[4]. - The company reported a significant increase in revenue for 2023, reaching RMB 1.2 billion, representing a growth of 25% compared to the previous year[16]. - The company achieved a revenue of approximately ¥405.57 million in 2023, representing an increase of 82.70% compared to ¥221.99 million in 2022[24]. - Net profit attributable to shareholders reached approximately ¥71.02 million, up 105.63% from ¥34.54 million in the previous year[24]. - The net profit after deducting non-recurring gains and losses was approximately ¥42.39 million, reflecting an 86.64% increase from ¥22.71 million in 2022[24]. - Basic and diluted earnings per share increased by 69.70% to ¥0.56 from ¥0.33 in 2022[25]. - The company's total assets grew by 245.65% to approximately ¥2.11 billion, compared to ¥610.40 million at the end of 2022[27]. - The net assets attributable to shareholders increased by 204.06% to approximately ¥1.58 billion from ¥520.62 million in the previous year[26]. - The company achieved a main business revenue of RMB 405.57 million in 2023, representing a year-on-year growth of 82.69%[36]. - The company reported a significant increase in sales volume and efficiency, contributing to the overall financial performance improvement[26]. Research and Development - Investment in R&D increased by 15%, totaling RMB 150 million, focusing on advanced semiconductor technologies[16]. - Research and development expenses accounted for 9.37% of total revenue, slightly up from 9.35% in 2022[25]. - R&D expenses increased by 83.10% to CNY 38.02 million, reflecting a significant investment in innovation[110]. - The increase in R&D expenses was primarily due to higher personnel costs, increased material investments, and additional travel expenses related to new product development[76]. - The company is committed to maintaining a high level of R&D investment to sustain its core competitiveness in the market[76]. - The company has a total of 11 ongoing R&D projects, with investments ranging from ¥190 million to ¥600 million, aimed at enhancing the efficiency and quality of silicon and silicon carbide production[78]. Market Expansion and Strategy - The company provided a positive outlook for 2024, projecting a revenue growth of 20% driven by new product launches and market expansion[16]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by 2025[16]. - A strategic acquisition of a local semiconductor firm was announced, expected to enhance production capacity by 40%[16]. - The company aims to become a leader in the domestic semiconductor crystal growth equipment sector, contributing to the development of China's semiconductor industry[34]. - The company has established stable partnerships with leading domestic silicon wafer manufacturers, enhancing its market position and product supply capabilities[66]. Operational Efficiency and Cost Management - Gross margin improved to 35%, up from 30% in the previous year, due to cost optimization strategies[16]. - The company aims to reduce operational costs by 10% through automation and process improvements[16]. - The company has implemented new strategies to improve operational efficiency, which is expected to reduce costs by 5% in the upcoming year[179]. Risks and Compliance - The company has outlined potential risks in its management discussion and analysis section, advising investors to be cautious[4]. - The company faces risks related to technology research and development, including potential failures in product technology upgrades and slow R&D progress, which could negatively impact its market competitiveness[95]. - The company is exposed to financial risks, including accounts receivable collection risks and inventory impairment risks, which could affect asset quality and profitability[100][101]. - The company is committed to improving its governance structure and ensuring compliance with relevant laws and regulations to protect stakeholder interests[163]. Corporate Governance - The company has not disclosed any special arrangements for corporate governance, indicating standard practices are in place[7]. - The company held 1 annual general meeting and 3 extraordinary general meetings during the reporting period, ensuring compliance with regulations to protect minority shareholders' rights[164]. - The company adhered to information disclosure regulations, ensuring that all shareholders had equal access to information, thereby protecting investor interests[168]. - The board of directors emphasized investor relations management, utilizing multiple channels to enhance communication with investors, particularly small and medium-sized investors[169].

Financial Performance - The company's operating revenue for Q1 2024 reached ¥81,107,784.99, representing a year-on-year increase of 111.29%[5] - Net profit attributable to shareholders was ¥14,817,697.06, a significant increase of 507.43% compared to the same period last year[5] - The net cash flow from operating activities was ¥71,185,103.18, reflecting a year-on-year increase of 277.02%[5] - Basic earnings per share were ¥0.11, up 450.00% from the previous year[6] - The company reported a significant increase in profit due to higher sales revenue and increased investment income[10] - In Q1 2024, the company reported a net profit of CNY 14,817,697.06, a significant increase from CNY 2,439,410.75 in Q1 2023, representing a growth of approximately 508%[20] - Operating profit for Q1 2024 was CNY 15,761,541.01, compared to CNY 2,124,147.86 in the same period last year, indicating a year-over-year increase of about 642%[20] - Total revenue from sales and services received in cash was CNY 151,112,872.83, a substantial increase from CNY 28,347,869.45 in Q1 2023, indicating a growth of approximately 433%[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,100,341,967.70, a slight decrease of 0.45% from the end of the previous year[6] - The total assets of the company as of March 31, 2024, were RMB 2,100,341,967.70, slightly down from RMB 2,109,856,954.53 at the end of 2023, a decrease of 0.3%[16] - The total liabilities decreased to RMB 508,229,678.59 as of March 31, 2024, from RMB 526,864,684.20 at the end of 2023, a reduction of 3.5%[16] Cash Flow - The company's cash and cash equivalents as of March 31, 2024, amounted to RMB 182,489,632.01, up from RMB 171,945,939.01 as of December 31, 2023, indicating a growth of 7.6%[14] - The company generated cash inflows from operating activities amounting to CNY 152,413,224.77, up from CNY 28,675,369.44 in Q1 2023, marking a growth of approximately 431%[23] - Cash flow from investing activities showed a net outflow of CNY 49,418,228.53, slightly worsening from a net outflow of CNY 48,087,122.99 in Q1 2023[24] - The company’s cash and cash equivalents at the end of Q1 2024 totaled CNY 182,489,632.01, a significant increase from CNY 11,244,922.37 at the end of Q1 2023[24] Research and Development - Total R&D investment amounted to ¥10,651,828.44, which is 13.13% of operating revenue, a decrease of 4.49 percentage points year-on-year[6] - Research and development expenses rose to CNY 10,651,828.44 in Q1 2024, compared to CNY 6,762,077.19 in Q1 2023, an increase of approximately 57%[20] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 6,712[11] - The top ten shareholders held a combined 57.70% of the company's shares, with the largest shareholder owning 15.88%[11] Financial Management - The weighted average return on equity increased to 0.93%, up by 0.46 percentage points[6] - The company incurred financial expenses of CNY -324,797.17 in Q1 2024, a decrease from CNY -44,920.13 in Q1 2023, reflecting improved financial management[20] - The company reported investment income of CNY 2,269,246.05 in Q1 2024, up from CNY 612,166.68 in the previous year, representing a growth of about 270%[20]

证券代码：688478 证券简称：晶升股份 公告编号：2024-021 南京晶升装备股份有限公司 首次公开发行部分限售股及部分战略配售限售股 上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次股票上市类型为首发战略配售股份（限售期 12 月）；股票认购方式为 网下，上市股数为 2,761,377 股。南京晶升装备股份有限公司（以下简称"公司" 或"晶升股份"）确认，上市流通数量等于该限售期的全部战略配售股份数量。 本次股票上市类型为首发限售股份；股票认购方式为网下，上市股数为 58,743,370 股。 本次股票上市流通总数为 61,504,747 股。 本次股票上市流通日期为 2024 年 4 月 24 日。 一、本次上市流通的限售股类型 根据中国证券监督管理委员会于 2023 年 3 月 13 日出具的《关于同意南京晶 升装备股份有限公司首次公开发行股票注册的批复》（证监许可〔2023〕547 号）， 公司获准首次公开发行人民币普通股（A 股）34,591,524 股，并于 2023 年 ...

核查意见 华泰联合证券有限责任公司关于 南京晶升装备股份有限公司首次公开发行部分限售股及部 分战略配售限售股上市流通事项的核查意见 华泰联合证券有限责任公司（以下简称"华泰联合证券"或"保荐机构"） 作为南京晶升装备股份有限公司（以下简称"晶升股份"或"公司"）首次公开 发行股票并在科创板上市持续督导阶段的保荐机构，根据《证券发行上市保荐业 务管理办法》《科创板上市公司持续监管办法（试行）》《上海证券交易所科创板 股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范 运作》等有关规定，对晶升股份首次公开发行部分限售股及部分战略配售限售股 上市流通事项情况进行了认真、审慎的核查，并发表本核查意见，具体情况如下： 一、本次限售股份申请上市流通的基本情况 根据中国证券监督管理委员会于 2023 年 3 月 13 日出具的《关于同意南京晶 升装备股份有限公司首次公开发行股票注册的批复》（证监许可〔2023〕547 号）， 公司获准首次公开发行人民币普通股（A 股）34,591,524 股，并于 2023 年 4 月 24 日在上海证券交易所科创板上市。公司首次公开发行股票完成后，总股本为 138 ...

本次会议的召开符合《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下简称"《证券法》"）等法律、法规、部门规章以 及《南京晶升装备股份有限公司章程》（以下简称"《公司章程》"）的有关规定， 会议决议合法、有效。 二、 监事会会议审议情况 （一）审议通过《关于使用闲置自有资金进行现金管理的议案》 监事会认为：公司为使用闲置自有资金进行现金管理建立了安全保障措施， 能够确保公司日常运营和资金安全，不会影响公司日常资金周转及公司业务的正 常运营，公司使用闲置自有资金进行现金管理能够提高资金使用效率，为公司和 股东谋取较好的投资回报。该事项不会对公司经营活动造成不利影响，不存在损 害公司及全体股东，特别是中小股东利益的情形。监事会同意公司使用额度不超 过人民币 120,000 万元（含）的闲置自有资金进行现金管理。 表决结果：同意 3 人；不同意 0 人；弃权 0 人。 证券代码：688478 证券简称：晶升股份 公告编号：2024-019 南京晶升装备股份有限公司 第二届监事会第三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对 ...

证券代码：688478 证券简称：晶升股份 公告编号：2024-020 南京晶升装备股份有限公司 关于使用闲置自有资金进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 南京晶升装备股份有限公司（以下简称"公司"）于 2024 年 4 月 15 日召开 第二届董事会第四次会议及第二届监事会第三次会议，审议通过了《关于使用闲 置自有资金进行现金管理的议案》，同意公司及子公司在确保不影响公司正常生 产经营及资金安全的情况下，使用额度不超过人民币 120,000 万元的闲置自有资 金进行现金管理，购买安全性高、流动性好的具有合法经营资格的金融机构销售 的投资产品（包括但不限于保本型理财产品、结构性存款、定期存款、通知存款、 大额存单、协定存款及国债逆回购品种等），使用期限自第二届董事会第四次会 议审议通过之日起 12 个月内有效，在决议有效期内公司可根据理财产品或存款 类产品期限在可用资金额度内滚动使用。 董事会授权总经理在上述额度范围及期限内行使投资决策、签署相关文件 等事宜，具体事项由公司财务部负责组织实施。上述 ...

证券代码：688478 证券简称：晶升股份 公告编号：2024-018 一、回购股份基本情况 公司于 2024 年 2 月 19 日召开第二届董事会第三次会议，审议通过《关于以 集中竞价交易方式回购公司股份方案的议案》，同意公司使用自有资金通过上海 证券交易所交易系统以集中竞价交易方式回购公司部分股份，回购资金总额不低 于人民币 5,000 万元（含），不超过人民币 1 亿元（含）；回购价格不超过人民币 56.40 元/股（含）；回购期限自公司董事会审议通过本次回购公司股份方案之日 起 12 个月内。 具体内容详见公司分别于 2024 年 2 月 20 日、2024 年 2 月 23 日披露于上海 证券交易所网站（www.sse.com.cn）的《南京晶升装备股份有限公司关于以集中 竞价交易方式回购公司股份方案的公告》（公告编号：2024-011）、《南京晶升装备 股份有限公司关于以集中竞价交易方式回购公司股份的回购报告书》（公告编号： 2024-014）。 南京晶升装备股份有限公司 关于以集中竞价交易方式回购公司股份的回购进展 暨"提质增效重回报"行动方案进展的公告 本公司董事会及全体董事保证本公告内容不存 ...

投资者关系活动记录表 证券简称：晶升股份 股票代码：688478 编码：<2024-003> √特定对象调研 □分析师会议 □媒体采访 □业绩说明会 投资者关系活动类别 □新闻发布会 □路演活动 □现场参观 □其他 博时基金、大和证券、德邦证券、东吴证券、华安证券、 华泰证券、国海证券、嘉实基金、诺安基金、鹏华基金、 国君资管、博深实业、黑翼资产、红骅投资、山西证券、 西部证券、钦沐资产、睿华资本、双安资产、天风证券、 参与单位名称 西南证券、鑫元基金、寻常投资、长城基金、长城证券、 长江资管、中金资管、中信证券、中邮证券、 华夏未来资本、摩根大通证券、信达澳亚基金、 野村东方国际证券、东方财富证券、个人投资者 时间 2024-3-19 地点 公司会议室 公司接待人员姓名 董事长、总经理：李辉；董事会秘书、财务负责人：吴春生 问答环节 Q:请问碳化硅衬底8寸替代6寸的进展情况如何？ A:根据我们所了解到的市场情况，碳化硅8寸替代6寸的速度快于 ...

| --- | --- | --- | |-------|-------|-------| | 2023E | 2024E | 2025E | | 406 | 739 | 1110 | | 216 | 397 | 585 | | 3 | 4 | 6 | | 0 | 19 | 22 | | 75 | 86 | 138 | | 38 | 71 | 105 | | 1 | 7 | 12 | | -1 | -3 | -4 | | 3 | 4 | 3 | | 2 | 3 | 4 | | 3 | 4 | 4 | | 0 | 0 | 0 | | 82 | 162 | 249 | | 0 | 0 | 0 | | 0 | 0 | 0 | | 81 | 162 | 248 | | 9 | 16 | 24 | | 72 | 146 | 224 | | 0 | 0 | 0 | | 72 | 146 | 224 | | 84 | 176 | 272 | | 0.52 | 1.06 | 1.62 | 特别声明 深圳 北京 证券研究报告 | 公司动态点评 2024 年 02 月 29 日 晶升股份（688478.SH） | --- | - ...